GlassScriptPhysician profile
John J Mcsweeney
NPI 1124080858
$3,921.69
in general payments reported to CMS, 2019-2025
49 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,362 · 2022: $1,960 · 2023: $283 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.15 |
| Education | $113.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $488.75 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $276.95 | 2021-2025 | Enhertu, Lynparza |
| Seagen INC. | $265.07 | 2021-2022 | |
| Amgen INC. | $232.08 | 2021-2022 | |
| Janssen Biotech, INC. | $228.84 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $222.10 | 2021-2022 | |
| Genzyme Corporation | $191.76 | 2021-2022 | |
| Genentech USA, INC. | $166.84 | 2021-2025 | Xolair, Polivy, Lunsumio |
| Pfizer INC. | $160.28 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $154.22 | 2021-2023 | Opdivo |
| Takeda Pharmaceuticals U.S.A., INC. | $144.46 | 2021-2025 | Livtencity, Glassia |
| Glaxosmithkline, LLC. | $97.45 | 2021-2023 | Zejula |
| Celgene Corporation | $92.95 | 2021-2022 | |
| Cti Biopharma Corp. | $80.38 | 2022-2023 | Vonjo |
| Pharmacyclics LLC, An Abbvie Company | $75.34 | 2021-2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcsweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.